Barry S. Ticho
2022
In 2022, Barry S. Ticho earned a total compensation of $2.4M as Chief Medical Officer at Stoke Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Bonus | $20,712 |
|---|---|
| Non-Equity Incentive Plan | $186,407 |
| Option Awards | $1,697,431 |
| Salary | $470,723 |
| Other | $10,984 |
| Total | $2,386,257 |
Ticho received $1.7M in option awards, accounting for 71% of the total pay in 2022.
Ticho also received $20.7K in bonus, $186.4K in non-equity incentive plan, $470.7K in salary and $11K in other compensation.
Rankings
In 2022, Barry S. Ticho's compensation ranked 1,522nd out of 5,760 executives tracked by ExecPay. In other words, Ticho earned more than 73.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,522 out of 5,760 | 74th |
Division Manufacturing | 769 out of 3,136 | 76th |
Major group Chemicals And Allied Products | 300 out of 1,422 | 79th |
Industry group Drugs | 278 out of 1,323 | 79th |
Industry Pharmaceutical Preparations | 198 out of 969 | 80th |
Source: SEC filing on September 28, 2023.
Ticho's colleagues
We found two more compensation records of executives who worked with Barry S. Ticho at Stoke Therapeutics in 2022.